Story perspectives

Senate Delays Federal Hemp-Derived THC Ban Until 2026

8/8/2026

Left

Senate Delays

The Senate added a provision to a continuing resolution delaying the federal ban on hemp-derived THC products until Dec 11, 2026.
White House lobbying for the delay could benefit Susie Wiles’ son-in-law, MC Nutraceuticals CEO Bret Worley, raising conflict-of-interest concerns.
Lawmakers were lobbied by the White House to insert the postponement into stopgap spending bill.
FDA said delta-8 THC appeals to children, prompting Capito to accept extension to avoid shutdown.

Right

Senate Delays

The U.S. Senate inserted a provision into a continuing resolution that delays the federal ban on most hemp-derived THC products until Dec 11, 2026.
CMS Administrator Mehmet Oz wrote to the Senate, saying the amendment would undo gains that let disabled Americans access hemp-derived CBD via his $500 pilot.
Senator Ted Budd framed the ban as protecting children from hemp products marketed as candy.

Center

Senate Delays

The U.S. Senate added a provision to a resolution delaying the federal ban on hemp-derived THC products until Dec 11, 2026.
Hemp groups called the delay, lobbying for rules, while 35 attorneys general and Sen. Ted Budd seek to strip it.
The Hemp Roundtable and Hemp Beverage Alliance praised the delay and launched a lobbying campaign.
Sen. Ted Budd, with bipartisan backing, moved to repeal the delay, arguing the ban limits THC.

Blindspot

Reporters noted that the hemp-derived THC product delay could benefit White House Chief of Staff Susie Wiles’ son-in-law, MC Nutraceuticals CEO Bret Worley, raising conflict-of-interest concerns.
Within this story's sources, this angle appears mainly in Left-leaning coverage and receives less attention in Center- and Right-leaning coverage.

History

Historical Context

Hemp production stopped in the 1950s, revived in the 1990s, and the 2018 Farm Bill removed low-THC cannabis from Schedule I with a 0.3 % delta-9 THC cap. The loophole created a multi-billion-dollar intoxicating-hemp market, leading to a 2025 law that shifts to a total-THC standard effective Nov 12 2026. A Senate provision now delays the ban until Dec 11 2026, supported by Senator Ted Budd and the Hemp Roundtable.

1 of 5

Senate Delays

The Senate added a provision to a continuing resolution delaying the federal ban on hemp-derived THC products until Dec 11, 2026.
White House lobbying for the delay could benefit Susie Wiles’ son-in-law, MC Nutraceuticals CEO Bret Worley, raising conflict-of-interest concerns.
Lawmakers were lobbied by the White House to insert the postponement into stopgap spending bill.
FDA said delta-8 THC appeals to children, prompting Capito to accept extension to avoid shutdown.

1 / 5